Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial-Reference-Cited by-同舟云学术

Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial

Published:2017-06-12 Issue:10 Volume:76 Page:1716-1722
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Bouman Chantal AM,van Herwaarden Noortje,van den Hoogen Frank HJ,Fransen Jaap,van Vollenhoven Ronald F,Bijlsma Johannes WJ,Maas Aatke van der,den Broeder Alfons A

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference24 articles.

1. Biologics for rheumatoid arthritis: an overview of Cochrane reviews;Singh;Cochrane Database Syst Rev,2009

2. Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide danish DANBIO registry;Ornbjerg;Ann Rheum Dis,2013

3. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis;Singh;Lancet,2015

4. The influence of anti-TNF therapy upon incidence of keratinocyte skin Cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register;Mercer;Ann Rheum Dis,2012

5. Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases;Theibich;Clin Rheumatol,2014

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To stop or not to stop an asthma biologic, that is the question;Annals of Allergy, Asthma & Immunology;2024-09

2. Prevalence and Factors Associated with De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis: A Medicare Claims-Based Observational Study;Drugs & Aging;2024-06-20

3. Disease activity–guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study;Rheumatology;2024-02-12

4. Disease activity-guided dose reduction may be a long-term option for stable RA;Medicom Conference Report EULAR 2023;2023-07-31

5. OP0131 DISEASE ACTIVITY-GUIDED DOSE OPTIMIZATION INCLUDING DISCONTINUATION OF TNF-INHIBITORS IN RHEUMATOID ARTHRITIS IS EFFECTIVE FOR UP TO 10 YEARS: RESULTS OF THE DRESS STUDY;Scientific Abstracts;2023-05-30